Psoriasis, Psoriatic Arthritis
Conditions
Keywords
Decision Aid, Shared Decision-Making
Brief summary
The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.
Detailed description
Prior to the interventional study, we will develop a decision aid using design thinking. In this interventional study, we will implement and test a patient-centered decision aid for therapy selection among patients with psoriasis and/or psoriatic arthritis who are starting or switching to a new medication.
Interventions
OTHERDecision Aid
Participants will test decision aid prototypes that are designed to assist them in choosing a medication.
Sponsors
University of Pennsylvania
Pfizer
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Masking description
Participants will have a choice of decision aids (web or paper) and will not be blinded. The study team will be aware of each prototype and decision aid that participants use.
Intervention model description
Patients and providers will use a web-based or paper decision aid. They will not be assigned to specific arms or undergo randomized treatment.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age 18 years or older 2. Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist) 3. Treated at Penn In addition to the above, for the observation and implementation phases of the study: 4. Initiation of a new psoriasis or psoriatic arthritis treatment * Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation * Patients may be taking other traditional DMARDs. * A washout period is not required.
Exclusion criteria
1. Unable to give informed consent 2. Youth, under the age of 18 years 3. Patients without psoriasis or psoriatic arthritis 4. Not being treated at a Penn clinic In addition to the above, for the observation and implementation phases of the study: 5. Not starting or switching to a new medication
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient and provider self-reported perceptions of the decision aid as measured by satisfaction survey | Up to 24 months | Satisfaction survey to rate the decision aid and shared decision-making process |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of times decision aid was used in consultation for patients switching therapies or starting a new treatment. | Up to 24 months | Rates of of the decision aid use |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORAlexis Ogdie-Beatty, MD
University of Pennsylvania
Outcome results
None listed